Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Biomarkers and the role of mast cells as facilitators of inflammation and fibrosis in chronic kidney disease.

Owens EP, Vesey DA, Kassianos AJ, Healy H, Hoy WE, Gobe GC.

Transl Androl Urol. 2019 May;8(Suppl 2):S175-S183. doi: 10.21037/tau.2018.11.03. Review.

2.

Pharmacokinetics of enteric coated mycophenolate sodium in lupus nephritis (POEMSLUN).

Ranganathan D, Abdul-Aziz MH, John GT, McWhinney BC, Fassett RG, Healy H, Kubler P, Lim A, Lipman J, Purvey M, Roberts M, Reyaldeen R, Ungerer J, Roberts JA.

Ther Drug Monit. 2019 Jun 18. doi: 10.1097/FTD.0000000000000658. [Epub ahead of print]

PMID:
31219949
3.

Human Tissue-Resident Mucosal-Associated Invariant T (MAIT) Cells in Renal Fibrosis and CKD.

Law BMP, Wilkinson R, Wang X, Kildey K, Giuliani K, Beagley KW, Ungerer J, Healy H, Kassianos AJ.

J Am Soc Nephrol. 2019 Jul;30(7):1322-1335. doi: 10.1681/ASN.2018101064. Epub 2019 Jun 11.

PMID:
31186283
4.

Pigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis.

Giuliani KTK, Kassianos AJ, Healy H, Gois PHF.

Int J Mol Sci. 2019 Apr 23;20(8). pii: E1997. doi: 10.3390/ijms20081997. Review.

5.

Natural Killer Cells in Kidney Health and Disease.

Turner JE, Rickassel C, Healy H, Kassianos AJ.

Front Immunol. 2019 Mar 26;10:587. doi: 10.3389/fimmu.2019.00587. eCollection 2019. Review.

6.

Chronic kidney disease, Queensland: Profile of patients with chronic kidney disease from regional Queensland, Australia: A registry report.

Venuthurupalli SK, Healy H, Fassett R, Cameron A, Wang Z, Hoy WE.

Nephrology (Carlton). 2019 Jan 20. doi: 10.1111/nep.13567. [Epub ahead of print]

PMID:
30663166
7.

The Kidney Supportive Care programme: characteristics of patients referred to a new model of care.

Purtell L, Sowa PM, Berquier I, Scuderi C, Douglas C, Taylor B, Kramer K, Hoy W, Healy H, Bonner A.

BMJ Support Palliat Care. 2018 Dec 4. pii: bmjspcare-2018-001630. doi: 10.1136/bmjspcare-2018-001630. [Epub ahead of print]

PMID:
30514718
8.

The Role of Oxidative Stress and Inflammation in Acute Oxalate Nephropathy Associated With Ethylene Glycol Intoxication.

Wilson GJ, Gois PHF, Zhang A, Wang X, Law BMP, Kassianos AJ, Healy HG.

Kidney Int Rep. 2018 Jun 11;3(5):1217-1221. doi: 10.1016/j.ekir.2018.05.005. eCollection 2018 Sep. No abstract available.

9.

Body mass index in an Australian population with chronic kidney disease.

Chan S, Cameron A, Wang Z, Venuthurupalli SK, Tan KS, Healy HG, Hoy WE.

BMC Nephrol. 2018 Aug 20;19(1):209. doi: 10.1186/s12882-018-1006-2.

10.

Effector γδ T cells in human renal fibrosis and chronic kidney disease.

Law BM, Wilkinson R, Wang X, Kildey K, Lindner M, Beagley K, Healy H, Kassianos AJ.

Nephrol Dial Transplant. 2019 Jan 1;34(1):40-48. doi: 10.1093/ndt/gfy098.

PMID:
29897565
11.

Health service utilisation during the last year of life: a prospective, longitudinal study of the pathways of patients with chronic kidney disease stages 3-5.

Chambers S, Healy H, Hoy WE, Kark A, Ratanjee S, Mitchell G, Douglas C, Yates P, Bonner A.

BMC Palliat Care. 2018 Apr 5;17(1):57. doi: 10.1186/s12904-018-0310-8.

12.

Tracking patients with advanced kidney disease in the last 12 months of life.

Bonner A, Chambers S, Healy H, Hoy W, Mitchell G, Kark A, Ratanjee S, Yates P.

J Ren Care. 2018 Jun;44(2):115-122. doi: 10.1111/jorc.12239. Epub 2018 Feb 28.

PMID:
29493102
13.

CKD Screening and Surveillance in Australia: Past, Present, and Future.

Venuthurupalli SK, Hoy WE, Healy HG, Cameron A, Fassett RG.

Kidney Int Rep. 2017 Oct 6;3(1):36-46. doi: 10.1016/j.ekir.2017.09.012. eCollection 2018 Jan. Review.

14.

Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service.

Mahmood U, Healy HG, Kark A, Cameron A, Wang Z, Abeysekera R, Hoy WE.

BMC Nephrol. 2017 Dec 28;18(1):372. doi: 10.1186/s12882-017-0781-5.

15.

The increasing rates of acute interstitial nephritis in Australia: a single centre case series.

Wilson GJ, Kark AL, Francis LP, Hoy W, Healy HG, Mallett AJ.

BMC Nephrol. 2017 Oct 31;18(1):329. doi: 10.1186/s12882-017-0747-7.

16.

CKD.QLD: establishment of a chronic kidney disease [CKD] registry in Queensland, Australia.

Venuthurupalli SK, Hoy WE, Healy HG, Cameron A, Fassett RG.

BMC Nephrol. 2017 Jun 7;18(1):189. doi: 10.1186/s12882-017-0607-5.

17.

Unique molecular profile of exosomes derived from primary human proximal tubular epithelial cells under diseased conditions.

Wang X, Wilkinson R, Kildey K, Potriquet J, Mulvenna J, Lobb RJ, Möller A, Cloonan N, Mukhopadhyay P, Kassianos AJ, Healy H.

J Extracell Vesicles. 2017 Apr 21;6(1):1314073. doi: 10.1080/20013078.2017.1314073. eCollection 2017.

18.

A Randomized Controlled Trial to Determine the Appropriate Time to Initiate Peritoneal Dialysis after Insertion of Catheter (Timely PD Study).

Ranganathan D, John GT, Yeoh E, Williams N, O'Loughlin B, Han T, Jeyaseelan L, Ramanathan K, Healy H.

Perit Dial Int. 2017 Jul-Aug;37(4):420-428. doi: 10.3747/pdi.2016.00066. Epub 2017 Apr 13.

PMID:
28408711
19.

Ethambutol Is Cleared by a Contemporary High-Flux Hemodialyzer, and Drug Monitoring Ensures Safety and Therapeutic Effect.

Chew R, Jongbloed S, Jegatheesan D, Healy H, Ta K, Ungerer J, McWhinney B, Donovan P, Woods ML.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e01988-16. doi: 10.1128/AAC.01988-16. Print 2017 Jun.

20.

Interferon-γ production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression.

Law BMP, Wilkinson R, Wang X, Kildey K, Lindner M, Rist MJ, Beagley K, Healy H, Kassianos AJ.

Kidney Int. 2017 Jul;92(1):79-88. doi: 10.1016/j.kint.2017.02.006. Epub 2017 Apr 8.

PMID:
28396119

Supplemental Content

Loading ...
Support Center